The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orphan Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global Orphan Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Orphan drugs are medicines that are used to treat diseases that cannot be produced profitably without the assistance of the government because there are so few patients. Conditions that are treated are known as rare diseases.
This report is a detailed and comprehensive analysis for global Orphan Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Orphan Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Orphan Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Orphan Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Orphan Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Orphan Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Orphan Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amber Specialty Pharmacy, Alexion Pharmaceuticals (Astra AB), Johnson & Johnson, Novartis and Celgene (Bristol-Myers Squibb), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Orphan Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biopharmaceutical
Other
Market segment by Application
Child
Aldult
Market segment by players, this report covers
Amber Specialty Pharmacy
Alexion Pharmaceuticals (Astra AB)
Johnson & Johnson
Novartis
Celgene (Bristol-Myers Squibb)
AbbVie
GSK
Roche
Sanofi
Pfizer
Vertex
Merck & Co.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Orphan Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Orphan Drugs, with revenue, gross margin and global market share of Orphan Drugs from 2018 to 2023.
Chapter 3, the Orphan Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Orphan Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Orphan Drugs.
Chapter 13, to describe Orphan Drugs research findings and conclusion.
The global Orphan Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Orphan drugs are medicines that are used to treat diseases that cannot be produced profitably without the assistance of the government because there are so few patients. Conditions that are treated are known as rare diseases.
This report is a detailed and comprehensive analysis for global Orphan Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Orphan Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Orphan Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Orphan Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Orphan Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Orphan Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Orphan Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amber Specialty Pharmacy, Alexion Pharmaceuticals (Astra AB), Johnson & Johnson, Novartis and Celgene (Bristol-Myers Squibb), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Orphan Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biopharmaceutical
Other
Market segment by Application
Child
Aldult
Market segment by players, this report covers
Amber Specialty Pharmacy
Alexion Pharmaceuticals (Astra AB)
Johnson & Johnson
Novartis
Celgene (Bristol-Myers Squibb)
AbbVie
GSK
Roche
Sanofi
Pfizer
Vertex
Merck & Co.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Orphan Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Orphan Drugs, with revenue, gross margin and global market share of Orphan Drugs from 2018 to 2023.
Chapter 3, the Orphan Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Orphan Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Orphan Drugs.
Chapter 13, to describe Orphan Drugs research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Orphan Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Orphan Drugs by Type
1.3.1 Overview: Global Orphan Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Orphan Drugs Consumption Value Market Share by Type in 2022
1.3.3 Biopharmaceutical
1.3.4 Other
1.4 Global Orphan Drugs Market by Application
1.4.1 Overview: Global Orphan Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Child
1.4.3 Aldult
1.5 Global Orphan Drugs Market Size & Forecast
1.6 Global Orphan Drugs Market Size and Forecast by Region
1.6.1 Global Orphan Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Orphan Drugs Market Size by Region, (2018-2029)
1.6.3 North America Orphan Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Orphan Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Orphan Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Orphan Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Orphan Drugs Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Amber Specialty Pharmacy
2.1.1 Amber Specialty Pharmacy Details
2.1.2 Amber Specialty Pharmacy Major Business
2.1.3 Amber Specialty Pharmacy Orphan Drugs Product and Solutions
2.1.4 Amber Specialty Pharmacy Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amber Specialty Pharmacy Recent Developments and Future Plans
2.2 Alexion Pharmaceuticals (Astra AB)
2.2.1 Alexion Pharmaceuticals (Astra AB) Details
2.2.2 Alexion Pharmaceuticals (Astra AB) Major Business
2.2.3 Alexion Pharmaceuticals (Astra AB) Orphan Drugs Product and Solutions
2.2.4 Alexion Pharmaceuticals (Astra AB) Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alexion Pharmaceuticals (Astra AB) Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Orphan Drugs Product and Solutions
2.3.4 Johnson & Johnson Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Orphan Drugs Product and Solutions
2.4.4 Novartis Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Celgene (Bristol-Myers Squibb)
2.5.1 Celgene (Bristol-Myers Squibb) Details
2.5.2 Celgene (Bristol-Myers Squibb) Major Business
2.5.3 Celgene (Bristol-Myers Squibb) Orphan Drugs Product and Solutions
2.5.4 Celgene (Bristol-Myers Squibb) Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Celgene (Bristol-Myers Squibb) Recent Developments and Future Plans
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Orphan Drugs Product and Solutions
2.6.4 AbbVie Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AbbVie Recent Developments and Future Plans
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Orphan Drugs Product and Solutions
2.7.4 GSK Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GSK Recent Developments and Future Plans
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Orphan Drugs Product and Solutions
2.8.4 Roche Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Orphan Drugs Product and Solutions
2.9.4 Sanofi Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Orphan Drugs Product and Solutions
2.10.4 Pfizer Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer Recent Developments and Future Plans
2.11 Vertex
2.11.1 Vertex Details
2.11.2 Vertex Major Business
2.11.3 Vertex Orphan Drugs Product and Solutions
2.11.4 Vertex Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Vertex Recent Developments and Future Plans
2.12 Merck & Co.
2.12.1 Merck & Co. Details
2.12.2 Merck & Co. Major Business
2.12.3 Merck & Co. Orphan Drugs Product and Solutions
2.12.4 Merck & Co. Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Merck & Co. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Orphan Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Orphan Drugs by Company Revenue
3.2.2 Top 3 Orphan Drugs Players Market Share in 2022
3.2.3 Top 6 Orphan Drugs Players Market Share in 2022
3.3 Orphan Drugs Market: Overall Company Footprint Analysis
3.3.1 Orphan Drugs Market: Region Footprint
3.3.2 Orphan Drugs Market: Company Product Type Footprint
3.3.3 Orphan Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Orphan Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Orphan Drugs Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Orphan Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Orphan Drugs Market Forecast by Application (2024-2029)
6 North America
6.1 North America Orphan Drugs Consumption Value by Type (2018-2029)
6.2 North America Orphan Drugs Consumption Value by Application (2018-2029)
6.3 North America Orphan Drugs Market Size by Country
6.3.1 North America Orphan Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Orphan Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Orphan Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Orphan Drugs Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Orphan Drugs Consumption Value by Type (2018-2029)
7.2 Europe Orphan Drugs Consumption Value by Application (2018-2029)
7.3 Europe Orphan Drugs Market Size by Country
7.3.1 Europe Orphan Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Orphan Drugs Market Size and Forecast (2018-2029)
7.3.3 France Orphan Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Orphan Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Orphan Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Orphan Drugs Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Orphan Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Orphan Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Orphan Drugs Market Size by Region
8.3.1 Asia-Pacific Orphan Drugs Consumption Value by Region (2018-2029)
8.3.2 China Orphan Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Orphan Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Orphan Drugs Market Size and Forecast (2018-2029)
8.3.5 India Orphan Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Orphan Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Orphan Drugs Market Size and Forecast (2018-2029)
9 South America
9.1 South America Orphan Drugs Consumption Value by Type (2018-2029)
9.2 South America Orphan Drugs Consumption Value by Application (2018-2029)
9.3 South America Orphan Drugs Market Size by Country
9.3.1 South America Orphan Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Orphan Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Orphan Drugs Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Orphan Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Orphan Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Orphan Drugs Market Size by Country
10.3.1 Middle East & Africa Orphan Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Orphan Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Orphan Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Orphan Drugs Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Orphan Drugs Market Drivers
11.2 Orphan Drugs Market Restraints
11.3 Orphan Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Orphan Drugs Industry Chain
12.2 Orphan Drugs Upstream Analysis
12.3 Orphan Drugs Midstream Analysis
12.4 Orphan Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
